Interferon and Octreotide to Treat Zollinger-Ellison Syndrome and Advanced Non-B Islet Cell Cancer
Condition(s):Islet Cell Adenoma; Zollinger Ellison SyndromeLast Updated:July 2, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Islet Cell Adenoma; Zollinger Ellison SyndromeLast Updated:July 2, 2017Completed
Condition(s):Islet Cell Adenoma; Neoplasm Metastasis; Zollinger Ellison SyndromeLast Updated:March 4, 2008Completed
Condition(s):Islet Cell TumorLast Updated:December 20, 2016Terminated
Condition(s):Pancreatic Neuroendocrine TumorLast Updated:May 8, 2023Not yet recruiting
Condition(s):Well-differentiated Pancreatic Neuroendocrine TumorLast Updated:July 30, 2019Completed
Condition(s):Pancreatic Neuroendocrine Tumour MetastaticLast Updated:November 7, 2018Completed
Condition(s):Pancreatic Neuroendocrine TumorLast Updated:May 18, 2022Recruiting
Condition(s):Advanced Pancreatic Neuroendocrine TumorLast Updated:February 7, 2024Not yet recruiting
Condition(s):Pancreatic Neuroendocrine TumorLast Updated:December 6, 2023Not yet recruiting
Condition(s):Pancreatic Neuroendocrine TumorLast Updated:March 6, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.